Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?

Abstract:

:Therapeutic drug monitoring (TDM) plays a vital role in implementing precision medicine in inflammatory bowel disease (IBD), and may contribute to increased effectiveness, lower rates of drug toxicity and cost savings. While expert panels advocate the use of reactive TDM for anti-tumor necrosis factor (anti-TNF) agents, TDM is not yet widely recommended for non-anti TNF biologicals. We provide an overview of the observational evidence of the value of TDM in case of vedolizumab and ustekinumab. We also shed light on obstacles that need to be addressed before establishing wide acceptance of TDM in the field of IBD. In this respect, new analytical techniques and modelling approaches are being developed to further optimize efficacy of TDM and to facilitate general acceptance of this tool in personalizing IBD management.

journal_name

Curr Opin Pharmacol

authors

Alsoud D,Vermeire S,Verstockt B

doi

10.1016/j.coph.2020.09.002

subject

Has Abstract

pub_date

2020-12-01 00:00:00

pages

17-30

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(20)30082-5

journal_volume

55

pub_type

杂志文章,评审
  • Emerging therapies in bone metastasis.

    abstract::Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. Emerging treatments for metastatic bone disease have arisen from our understanding of the biology of bone metastases. Tumour cells alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells, prom...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.04.004

    authors: Clément-Demange L,Clézardin P

    更新日期:2015-06-01 00:00:00

  • Small molecule drugs - optimizing DNA damaging agent-based therapeutics.

    abstract::DNA-targeted chemotherapies remain fundamental in clinical management of both common solid tumours and hematologic malignancies. Recent studies indicate that novel combinations of cytotoxic chemotherapy may have significant activity even in tumours regarded as being resistant to conventional chemotherapy. In addition,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.03.008

    authors: Hartley JA,Hochhauser D

    更新日期:2012-08-01 00:00:00

  • What next for rheumatoid arthritis therapy?

    abstract::Introduction of biological agents for the treatment of the chronic inflammatory joint disease rheumatoid arthritis has reinvigorated research into this debilitating disease. These agents have been shown to both act on the signs and symptoms of disease, as well as retard the progression of joint destruction. However, t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.04.001

    authors: Blake SM,Swift BA

    更新日期:2004-06-01 00:00:00

  • Cholesterol and the development of clear-cell renal carcinoma.

    abstract::The majority of kidney cancers are clear-cell carcinomas (ccRCC), characterized by the accumulation of cholesterol, cholesterol esters, other neutral lipids and glycogen. Rather than being a passive bystander, the clear-cell phenotype is suggested to be a biomarker of deregulated cholesterol and lipid biosynthesis, wh...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.08.002

    authors: Drabkin HA,Gemmill RM

    更新日期:2012-12-01 00:00:00

  • Putative druggable targets for selective enhancement of cardiac conduction.

    abstract::Putative druggable targets to selectively enhance cardiac conduction can be considered from the level of the ion channels determining the initiation and duration of the cardiac action potential to the gap junction proteins responsible for optimal cellular electrical coupling. Nature has provided a number of inherited ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2008.11.008

    authors: Gomes J,Lambiase PD

    更新日期:2009-04-01 00:00:00

  • Osteocytes: The master cells in bone remodelling.

    abstract::Bone remodelling is an essential process for shaping and maintaining bone mass in the mature skeleton. During our lifetime bone is constantly being removed by osteoclasts and new bone is formed by osteoblasts. The activities of osteoclasts and osteoblasts must be regulated under a strict balance to ensure that bone ho...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.02.003

    authors: Prideaux M,Findlay DM,Atkins GJ

    更新日期:2016-06-01 00:00:00

  • Therapeutic potential of marine n-3 fatty acids in CABG patients.

    abstract::Dietary intake of marine n-3 polyunsaturated fatty acids (PUFA) has beneficial effects in various cardiac disorders. Few studies have, however, investigated the therapeutic potential of n-3 PUFA in patients undergoing coronary artery bypass grafting (CABG). Five heterogeneous randomized studies on n-3 PUFA for prevent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.01.012

    authors: Andreasen JJ,Schmidt EB

    更新日期:2012-04-01 00:00:00

  • Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

    abstract::Metabotropic glutamate receptors (mGluRs) are heavily expressed throughout the basal ganglia (BG), where they modulate neuronal excitability, transmitter release and long term synaptic plasticity. Therefore, targeting specific mGluR subtypes by means of selective drugs could be a possible strategy for restoring normal...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.03.004

    authors: Masilamoni GJ,Smith Y

    更新日期:2018-02-01 00:00:00

  • Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.

    abstract::Oxidation-specific epitopes (OSE), present on oxidized LDL (OxLDL), apoptotic cells, cell debris and modified proteins in the vessel wall, accumulate in response to hypercholesterolemia, and generate potent pro-inflammatory, disease-specific antigens. They represent an important class of 'danger associated molecular p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.02.005

    authors: Leibundgut G,Witztum JL,Tsimikas S

    更新日期:2013-04-01 00:00:00

  • Opioid-receptor-heteromer-specific trafficking and pharmacology.

    abstract::Homomerization and heteromerization of 7 transmembrane spanning (7TM)/G-protein-coupled receptors (GPCRs) have been an important field of study. Whereas initial studies were performed in artificial cell systems, recent publications are shifting the focus to the in vivo relevance of heteromerization. This is especially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.007

    authors: van Rijn RM,Whistler JL,Waldhoer M

    更新日期:2010-02-01 00:00:00

  • Aptamers as candidate therapeutics for cardiovascular indications.

    abstract::The first therapeutic aptamer was approved for human use in 2004, and a range of chemical substitutions that improve the drug-like properties of aptamers has recently been shown to increase the utility of this modality. Currently there are both anticoagulant and antithrombotic aptamers in the clinic, and additionally ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.005

    authors: Keefe AD,Schaub RG

    更新日期:2008-04-01 00:00:00

  • Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs.

    abstract::After a decade of intense pharmacological and drug development activity by the pharmaceutical industry, compounds derived from two key strategies for reducing gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs) have been subjected to rigorous clinical appraisal. Despite the undoubted therapeutic...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.08.003

    authors: Whittle BJ

    更新日期:2004-12-01 00:00:00

  • Mechanism of action of general anaesthetics--new information from molecular pharmacology.

    abstract::Major progress in our understanding of the mechanisms of anaesthesia has been made during the past year. Several key advances in defining very specific sites of action on ligand-gated ion channels have been described. Furthermore, new techniques have become available for addressing the identification of binding sites ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00013-3

    authors: Thompson SA,Wafford K

    更新日期:2001-02-01 00:00:00

  • Central nervous system control of cough: pharmacological implications.

    abstract::For many years the idea of a cough center in the brain dominated discussions in the field without any substantial progress in defining what this cough center is or how it functions. Substantial progress has now been made and many of the central neural elements involved in coughing are being described. Furthermore, hyp...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.05.005

    authors: Mazzone SB,McGovern AE,Cole LJ,Farrell MJ

    更新日期:2011-06-01 00:00:00

  • Synaptic localization of neurotransmitter receptors: comparing mechanisms for AMPA and GABAA receptors.

    abstract::Ionotropic neurotransmitter receptors mediate fast synaptic transmission by localizing at postsynapses. Changes in receptor number at synapses induce synaptic plasticity. Thus, mechanisms for the synaptic localization of receptors in basal transmission and synaptic plasticity have been investigated extensively. Recent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.11.011

    authors: Martenson JS,Tomita S

    更新日期:2015-02-01 00:00:00

  • Porous silicon advances in drug delivery and immunotherapy.

    abstract::Biomedical applications of porous silicon include drug delivery, imaging, diagnostics and immunotherapy. This review summarizes new silicon particle fabrication techniques, dynamics of cellular transport, advances in the multistage vector approach to drug delivery, and the use of porous silicon as immune adjuvants. Re...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.06.006

    authors: Savage DJ,Liu X,Curley SA,Ferrari M,Serda RE

    更新日期:2013-10-01 00:00:00

  • Image-free assessment of protein translocation in live cells.

    abstract::Protein translocation is a universal event shared by most cell signalling pathways to transmit signals between cell compartments. In recent years, the use of new fluorescence microscopy technologies combined with fluorescent probes--most often fluorescent proteins--and image analysis software has allowed the visualiza...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.07.002

    authors: Furger C,Derick S,Boutin JA,Nosjean O

    更新日期:2009-10-01 00:00:00

  • Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do.

    abstract::Diabetes diagnosed in adults is a highly heterogeneous disorder. It mostly consists of what is referred to as type 2 diabetes but also comprises other entities (i.e. different diseases), including latent autoimmune diabetes, late onset forms of monogenic diabetes and familial diabetes of the adulthood, which has recen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.020

    authors: Trischitta V,Prudente S,Doria A

    更新日期:2020-12-01 00:00:00

  • Inhibition of poly(ADP-ribose) polymerase in cancer.

    abstract::Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase-1 (PARP-1) has been extensively investigated in the pre-clinical setting as a strategy for chemo- or radio-potentiation. Recent evidence has suggested that PARP inhibitors might be active as single agents in certain rare inherited cancers that carry DNA r...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.02.004

    authors: Plummer ER

    更新日期:2006-08-01 00:00:00

  • Src and focal adhesion kinase as therapeutic targets in cancer.

    abstract::Over the past few years small molecule inhibitors of both Src family kinases and focal adhesion kinase (FAK) have entered clinical studies for the treatment of solid tumours. These adhesion-linked kinases are involved in a number of pathways that have impact on the behaviour of tumour cells and the challenge is now, h...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.06.012

    authors: Brunton VG,Frame MC

    更新日期:2008-08-01 00:00:00

  • SIRT1 - a metabolic sensor that controls blood vessel growth.

    abstract::Blood vessels deliver nutrients and oxygen to cells and tissues in the body. When blood supply is insufficient new vessels form to meet the metabolic tissue requirements. Several studies have examined the cellular and molecular principles of blood vessel formation, yet little is known about how vessels sense and integ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.01.001

    authors: Guarani V,Potente M

    更新日期:2010-04-01 00:00:00

  • Brk/PTK6 signaling in normal and cancer cell models.

    abstract::Breast tumor kinase (Brk), also termed PTK6, is known to function in cell-type and context-dependent processes governing normal differentiation. However, in tumors in which Brk is overexpressed, this unusual soluble tyrosine kinase is emerging as a mediator of cancer cell phenotypes, including increased proliferation,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.08.007

    authors: Ostrander JH,Daniel AR,Lange CA

    更新日期:2010-12-01 00:00:00

  • Human pluripotent stem cells for the modelling of diseases of the retina and optic nerve: toward a retina in a dish.

    abstract::Human pluripotent stem cells can be differentiated into specific, relevant cell types of interest including the cells of the retina and optic nerve. These cells can then be used to study fundamental biology as well as disease modelling and subsequent screening of potential treatments. Many models of differentiation an...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.003

    authors: Lidgerwood GE,Hewitt AW,Pébay A

    更新日期:2019-10-01 00:00:00

  • Thrombomodulation via CLEC-2 targeting.

    abstract::CLEC-2 is a C-type lectin-like molecule that has recently been identified as a receptor on the surface of platelets. Ligand binding by CLEC-2 promotes phosphorylation of a tyrosine in the cytoplasmic domain YXXL motif of CLEC-2 by Src kinases and further downstream signalling events trigger platelet activation and agg...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.11.001

    authors: O'Callaghan CA

    更新日期:2009-04-01 00:00:00

  • The case for a role for adenosine in asthma: almost convincing?

    abstract::Mice rendered adenosine deaminase-deficient manifest an 'asthma' phenotype in the lungs that includes mast cell degranulation, eosinophilia, mucus hypersecretion and bronchial hyperresponsiveness. These changes can be reversed by enzyme therapy with adenosine deaminase, and attenuated by theophylline. Theophylline als...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00039-0

    authors: Fozard JR

    更新日期:2003-06-01 00:00:00

  • Receptor classification: post genome.

    abstract::Most of the G-protein-coupled receptors (GPCRs) in the human genome have been described. Investigation will now shift from discovery to analysis. Like many other genes, those encoding GPCRs are frequently found adjacent to each other in clusters. Duplicated genes often share ligands, signalling pathways and amino acid...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00214-x

    authors: Foord SM

    更新日期:2002-10-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • Therapeutic strategies to halt renal fibrosis.

    abstract::Angiotensin II blockade has become a standard anti-fibrotic therapy in renal diseases because it slows progression to end-stage renal disease. However, current data support the notion that angiotensin II blockade alone cannot stop progressive fibrotic disease. Of an increasing number of therapies showing efficacy in a...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00144-3

    authors: Yu L,Noble NA,Border WA

    更新日期:2002-04-01 00:00:00

  • Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agents.

    abstract::In the current of era of developing antibacterial agents, including those for unmet medical need, Sponsors are required to submit a robust pre-clinical pharmacokinetic-pharmacodynamic (PK-PD) data package in exchange for limited clinical data. However, the clinical data package also needs to be as robust as possible. ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.010

    authors: Bhavnani SM,Hammel JP

    更新日期:2017-10-01 00:00:00

  • Purinergic signalling in the lung: important in asthma and COPD?

    abstract::During the past decade, evidence has accumulated for the involvement of purines and purine receptors in the pathogenesis and pathophysiology of asthma and chronic obstructive pulmonary diseases. In particular, the indirect bronchospasmic and inflammatory actions of purines via the activation and degranulation of mast ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.01.010

    authors: Adriaensen D,Timmermans JP

    更新日期:2004-06-01 00:00:00